Wright Investors Service Inc. purchased a new position in Genpact Limited (NYSE:G - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,391 shares of the business services provider's stock, valued at approximately $457,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cetera Investment Advisers boosted its position in shares of Genpact by 4.7% during the 4th quarter. Cetera Investment Advisers now owns 13,269 shares of the business services provider's stock valued at $570,000 after acquiring an additional 595 shares during the last quarter. Deutsche Bank AG increased its stake in Genpact by 485.5% in the fourth quarter. Deutsche Bank AG now owns 14,110 shares of the business services provider's stock worth $606,000 after purchasing an additional 11,700 shares during the period. Focus Partners Wealth purchased a new stake in Genpact in the fourth quarter worth $204,000. ProShare Advisors LLC increased its stake in Genpact by 6.2% in the fourth quarter. ProShare Advisors LLC now owns 7,591 shares of the business services provider's stock worth $326,000 after purchasing an additional 445 shares during the period. Finally, State of Wyoming grew its position in shares of Genpact by 302.7% during the 4th quarter. State of Wyoming now owns 6,536 shares of the business services provider's stock worth $281,000 after buying an additional 4,913 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on G shares. JPMorgan Chase & Co. cut their target price on Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft started coverage on Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 price target for the company. Mizuho raised their price target on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. Needham & Company LLC raised their price target on Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Finally, Wall Street Zen downgraded Genpact from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $52.29.
Read Our Latest Stock Report on G
Genpact Price Performance
Shares of NYSE G traded down $0.30 during trading on Tuesday, hitting $40.86. The company had a trading volume of 592,782 shares, compared to its average volume of 1,644,003. The firm has a market capitalization of $7.12 billion, a price-to-earnings ratio of 13.60, a price-to-earnings-growth ratio of 1.41 and a beta of 0.92. The stock has a fifty day simple moving average of $43.97 and a two-hundred day simple moving average of $45.37. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. Genpact Limited has a fifty-two week low of $37.82 and a fifty-two week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period last year, the company posted $0.79 EPS. Genpact's quarterly revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, research analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Thursday, September 11th. Genpact's dividend payout ratio is 22.59%.
Insider Activity
In related news, CEO Balkrishan Kalra sold 55,000 shares of the business's stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the transaction, the chief executive officer directly owned 295,246 shares in the company, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares of the company's stock, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.80% of the company's stock.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report